Thanks mate.
Well if the results are positive I make money and OCC should then do another study which puts the nail in the coffin so to speak. Even a few case studies using UTC will get heads turning as degenerative tendons do not have a natural recovery. There is nothing right now that reverses the structure/health so to speak, of a degenerative tendon. It is only a reduction of symptoms and an increase of function though multiple proposed mechanisms. Some proposed mechanisms off the top of my head are increased local/global muscle strength, changes in the healthy non degenerative tendons (the Donut), desensitisation of pain on a central level and increase in tolerance of stress shielding of a bursa to compressional forces in insertional tendinopathy.
If the results show no efficacy in the trial...to be honest I don't know what they should do. Tendinopathy is complex and multifactoral so if a specific subgroup of individuals improve significantly whereas some don't, they should then do a study with an inclusion/exclusion criteria. Some exclusion criteria/risk factors of poor prognosis for tendinopathy are
diabetes/overweight/age/gender/expectations of treatment and compliance to treatment.
- Forums
- ASX - By Stock
- OCC
- Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-142
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 23269 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 25000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 23269 | 0.385 |
4 | 20914 | 0.380 |
5 | 81340 | 0.375 |
10 | 112676 | 0.370 |
4 | 80622 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 25000 | 2 |
0.400 | 290626 | 12 |
0.405 | 65143 | 3 |
0.410 | 157677 | 7 |
0.415 | 3200 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online